Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 18/20 | 0.44 |
| ▸ | CTSB | P07858 | 6/20 | 0.43 |
| ▸ | CTSS | P25774 | 6/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14384118 | 1.00 | CTSK (0.44) | CTSKCTSBCTSSL3MBTL1KAT6A | |
| SCHEMBL5630402 | 0.86 | L3MBTL1 (0.44) | CTSKCTSBCTSSL3MBTL1KAT6A | |
| SCHEMBL5631800 | 0.86 | L3MBTL1 (0.44) | CTSKCTSBCTSSL3MBTL1KAT6A | |
| SCHEMBL5632779 | 0.86 | L3MBTL1 (0.44) | CTSKCTSBCTSSL3MBTL1KAT6A | |
| SCHEMBL5630394 | 0.86 | L3MBTL1 (0.44) | CTSKCTSBCTSSL3MBTL1KAT6A | |
| SCHEMBL5631803 | 0.86 | L3MBTL1 (0.44) | CTSKCTSBCTSSL3MBTL1KAT6A | |
| SCHEMBL14384115 | 0.84 | L3MBTL1 (0.44) | CTSKCTSBCTSSL3MBTL1KAT6A | |
| SCHEMBL14384114 | 0.84 | L3MBTL1 (0.44) | CTSKCTSBCTSSL3MBTL1KAT6A | |
| SCHEMBL5632090 | 0.77 | L3MBTL1 (0.43) | CTSKCTSBCTSSL3MBTL1KAT6A | |
| SCHEMBL6611788 | 0.77 | L3MBTL1 (0.48) | CTSKCTSBCTSSL3MBTL1KAT6A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7288541-B2 | Propylcarbamate derivatives as inhibitors of serine and cysteine proteases | SMITHKLINE BEECHAM CORPORATION (US) | 2007-10-30 | — | — | US | disclosed |
| US-7288541-B2 | Propylcarbamate derivatives as inhibitors of serine and cysteine proteases | SMITHKLINE BEECHAM CORPORATION (US) | 2007-10-30 | — | — | US | disclosed |